[1] HARRISON MR, GOLBUS MS, FILLY RA, et al. Fetal surgery for congenital hydronephrosis. N Engl J Med. 1982;306(10):591-593.
[2] KOVLER ML, JELIN EB. Fetal intervention for congenital diaphragmatic hernia. Semin Pediatr Surg. 2019;28(4):150818.
[3] DANZER E, JOYEUX L, FLAKE AW, et al. Fetal surgical intervention for myelomeningocele: lessons learned, outcomes, and future implications. Dev Med Child Neurol. 2020;62(4):417-425.
[4] HOLWERDA JC, VAN LINDERT EJ, BUIS DR, et al. Surgical intervention for hydrocephalus in infancy; etiology, age and treatment data in a Dutch cohort. Childs Nerv Syst. 2020;36(3):577-582.
[5] ZHANG J, CHEN H, KORNREICH R, et al. Prenatal Diagnosis of Tay-Sachs Disease. Methods Mol Biol. 2019;1885:233-250.
[6] MOMOSAKI K, KIDO J, MATSUMOTO S, et al. The Effect of S-Adenosylmethionine Treatment on Neurobehavioral Phenotypes in Lesch-Nyhan Disease: A Case Report. Case Rep Neurol. 2019;11(3): 256-264.
[7] WROBLEWSKI M, SCHELLER-WENDORFF M, UDONTA F, et al. BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells. Haematologica. 2018;103(6):939-948.
[8] GAO P, CHEN C, HOWELL ED, et al. Transcriptional regulatory network controlling the ontogeny of hematopoietic stem cells. Genes Dev. 2020;34(13-14):950-964.
[9] ANDERSON D, BILLINGHAM RE, LAMPKIN GH, et al. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity. 1951;5(3):379-397.
[10] SAGAR R, GÖTHERSTRÖM C, DAVID AL, et al. Fetal stem cell transplantation and gene therapy. Best Pract Res Clin Obstet Gynaecol. 2019;58:142-153.
[11] RODRIGUEZ M, PORADA CD, ALMEIDA-PORADA G. Mechanistic Insights into Factor VIII Immune Tolerance Induction via Prenatal Cell Therapy in Hemophilia A. Curr Stem Cell Rep. 2019;5(4):145-161.
[12] ALHAJJAT A, SHAABAN A. Maternal and Fetal Immune Response to in Utero Stem Cell Transplantation. Curr Stem Cell Rep. 2018;4(2): 182-187.
[13] PERANTEAU WH, HAYASHI S, ABDULMALIK O, et al. Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants. Blood. 2015; 126(10):1245-1254.
[14] AHN NJ, STRATIGIS JD, COONS BE, et al. Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model. J Vis Exp. 2018;(140):58047.
[15] ALMEIDA-PORADA G, ATALA A, PORADA CD. In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application. Mol Ther Methods Clin Dev. 2016;5:16020.
[16] BILLINGHAM RE, BRENT L, MEDAWAR PB. Actively acquired tolerance of foreign cells. Nature. 1953;172(4379):603-606.
[17] FLEISCHMAN RA, MINTZ B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta. Proc Natl Acad Sci U S A. 1979;76(11):5736-5740.
[18] BLAZAR BR, TAYLOR PA, VALLERA DA. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood. 1995;85(3): 833-841.
[19] LOUKOGEORGAKIS SP, SHANGARIS P, BERTIN E, et al. In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long-Term Hematopoietic Engraftment. Stem Cells. 2019; 37(9):1176-1188.
[20] SHANGARIS P, LOUKOGEORGAKIS SP, BLUNDELL MP, et al. Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice. Stem Cells Dev. 2018;27(8):515-523.
[21] MAGNANI A, JOUANNIC JM, ROSAIN J, et al. Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency. Blood Adv. 2019;3(3):237-241.
[22] CARRIER E, GILPIN E, LEE TH, et al. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity. J Lab Clin Med. 2000;136(3):224-235.
[23] LEVEQUE L, KHOSROTEHRANI K. Feto-maternal allo-immunity, regulatory T cells and predisposition to auto-immunity. Does it all start in utero? Chimerism. 2014;5(2):59-62.
[24] JAVAZON EH, MERCHANT AM, DANZER E, et al. Reconstitution of hematopoiesis following intrauterine transplantation of stem cells. Methods Mol Med. 2005;105:81-94.
[25] DURKIN ET, JONES KA, RAJESH D, et al. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood. 2008;112(13):5245-5253.
[26] ALHAJJAT AM, LEE AE, STRONG BS, et al. NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation. Front Pharmacol. 2015;6:51.
[27] ABUMAREE MH, BAHATTAB E, ALSADOUN A, et al. Characterization of the interaction between human decidua parietalis mesenchymal stem/stromal cells and natural killer cells. Stem Cell Res Ther. 2018;9(1):102.
[28] PeRANTEAU WH, HEATON TE, GU YC, et al. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biol Blood Marrow Transplant. 2009;15(3):293-305.
[29] VRECENAK JD, PEARSON EG, SANTORE MT, et al. Stable long-term mixed chimerism achieved in a canine model of allogeneic in utero hematopoietic cell transplantation. Blood. 2014;124(12):1987-1995.
[30] VRECENAK JD, PARTRIDGE EA, PEARSON EG, et al. Simple Approach to Increase Donor Hematopoietic Stem Cell Dose and Improve Engraftment in the Murine Model of Allogeneic In Utero Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020;26(1):e21-e24.
[31] DONAHUE J, GILPIN E, LEE TH, et al. Microchimerism does not induce tolerance and sustains immunity after in utero transplantation. Transplantation. 2001;71(3):359-368.
[32] WALKER JA, VUYYURU R, MANSER T, et al. Humoral Immunity in Mice Transplanted with Hematopoietic Stem Cells Derived from Human Umbilical Cord Blood Recapitulates That of Human Infants. Stem Cells Dev. 2017;26(23):1715-1723.
[33] NGUYEN QH, WITT RG, WANG B, et al. Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with Mucopolysaccharidosis type VII. Sci Transl Med. 2020; 12(532):eaay8980.
[34] KREGER EM, SINGER ST, WITT RG, et al. Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature. Prenat Diagn. 2016;36(13):1242-1249.
[35] MCCLAIN LE, FLAKE AW. In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application. Best Pract Res Clin Obstet Gynaecol. 2016;31:88-98.
[36] DEMERDASH Z, EL BAZ H, ALI N, et al. Cloning of human cord blood-mesenchymal stem cells for isolation of enriched cell population of higher proliferation and differentiation potential. Mol Biol Rep. 2020;47(5):3963-3972.
[37] SANGEETHA KN, VENNILA R, SECUNDA R, et al. Functional variations between Mesenchymal Stem Cells of different tissue origins: A comparative gene expression profiling. Biotechnol Lett. 2020;42(7): 1287-1304.
[38] LIECHTY KW, MACKENZIE TC, SHAABAN AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6(11):1282-1286.
[39] CHAN J, WADDINGTON SN, O’DONOGHUE K, et al. Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells. 2007;25(4):875-884.
[40] BIER A, BERENSTEIN P, KRONFELD N, et al. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy. Biomaterials. 2018;174:67-78.
[41] GUILLOT PV, ABASS O, BASSETT JH, et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood. 2008;111(3):1717-1725.
[42] WANG A, BROWN EG, LANKFORD L, et al. Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele. Stem Cells Transl Med. 2015;4(6):659-669.
[43] DE COPPI P, BARTSCH G JR, SIDDIQUI MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1): 100-106.
[44] GHOLIZADEH-GHALEH AZIZ S, FARDYAZAR Z, PASHAIASL M. The human amniotic fluid mesenchymal stem cells therapy on, SKOV3, ovarian cancer cell line. Mol Genet Genomic Med. 2019;7(7):e00726.
[45] WEBER B, EMMERT MY, BEHR L, et al. Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials. 2012;33(16):4031-4043.
[46] SHAW SWS, BOLLINI S, NADER KA, et al. Autologous Transplantation of Amniotic Fluid-Derived Mesenchymal Stem Cells into Sheep Fetuses. Cell Transplant. 2016;25(3):615.
[47] ABE Y, OCHIAI D, MASUDA H, et al. In Utero Amniotic Fluid Stem Cell Therapy Protects Against Myelomeningocele via Spinal Cord Coverage and Hepatocyte Growth Factor Secretion. Stem Cells Transl Med. 2019;8(11):1170-1179.
[48] SANTORE MT, ROYBAL JL, FLAKE AW. Prenatal stem cell transplantation and gene therapy. Clin Perinatol. 2009;36(2):451-471.
[49] WEGORZEWSKA M, NIJAGAL A, WONG CM, et al. Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise. J Immunol. 2014;192(4): 1938-1945.
[50] DERDERIAN SC, TOGARRATI PP, KING C, et al. In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice. Blood. 2014;124(6):973-980.
|